Skip to content

Check out the latest issue of PxWire here! And see key highlights below:

  • New research provides reassuring evidence that oral PrEP can reliably prevent HIV infection in cisgender women even with non-perfect adherence.
  • This year, Canada, Mozambique, Tanzania, and the UK approved injectable cabotegravir, and it’s now under review in Taiwan.
  • Malawi, Zambia and Zimbabwe are the second, third and fourth countries now rolling out injectable CAB outside the planned and ongoing implementation science studies.